Navigation Links
AtriCure Reports Third Quarter 2007 Financial Results
Date:11/6/2007

for the ablation, or destruction, of soft tissues in general and cardiac related surgical procedures, but to date has not cleared or approved the system for the treatment of AF. The FDA has cleared the AtriCure multifunctional bipolar Pen for the ablation of cardiac tissue and for temporary pacing, sensing, stimulating and recording during the evaluation of cardiac arrhythmias, but the multifunctional bipolar Pen has not been approved for the treatment of AF.

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward- looking statements include statements that address activities, events or developments that AtriCure expects, believes or anticipates will or may occur in the future, such as earnings estimates, other predictions of financial performance, launches by AtriCure of new products and market acceptance of AtriCure's products. Forward-looking statements are based on AtriCure's experience and perception of current conditions, trends, expected future developments and other factors it believes are appropriate under the circumstances and are subject to numerous risks and uncertainties, many of which are beyond AtriCure's control. These risks and uncertainties include the rate and degree of market acceptance of AtriCure's products, AtriCure's ability to develop and market new and enhanced products, the timing of and ability to obtain and maintain regulatory clearances and approvals for its products, the timing of and ability to obtain reimbursement of procedures utilizing AtriCure's products, competition from existing and new products and procedures or AtriCure's ability to effectively react to other risks and uncertainties described from time to time in AtriCure's SEC filings, such as fluctuation of quarterly financial results, reliance on third party manufacturers and suppliers, litigation (including the purported class action lawsuit) or other
'/>"/>

SOURCE AtriCure, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
4. AtriCure to Present at ThinkEquity Partners 5th Annual Growth Conference
5. Published Results Using AtriCure Minimally Invasive Products
6. AtriCure Announces Web Cast and Conference Call of Third Quarter 2007 Financial Results
7. AtriCure Ranked 80th in Deloittes Technology Fast 500
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. Haemacure Reports Third Quarter 2007 Results
10. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... ... and Lita Hart, icons of the network marketing industry and founders of the Healthy ... Movement of EvolvHealth. In what has been a long-term relationship between the companies for ... of purpose together to change the course of the network marketing industry. , “This ...
(Date:8/1/2015)... ... 01, 2015 , ... BeverlyD, owner and founder of BeverlyD Luxe Organic Hair ... first small business donation to kick off the campaign for healing and Well-Being. , ... includes a complete line of raw, organic hair care products, as well as her ...
(Date:7/31/2015)... ... , ... Ticket Down is a reputable source of authentic tickets for the 2015 iHeart ... of every genre of music will have an act they are excited to see at ... the following artists will perform: Sam Smith, Coldplay, Kenny Chesney, The Who, Jason Derulo, ...
(Date:7/31/2015)... IL (PRWEB) , ... July 31, 2015 , ... Ticket ... which is currently going on in Chicago at Grant Park. The festival will ... corner of North America to Chicago for the annual Lollapalooza. This unique and ...
(Date:7/31/2015)... ... ... The 2nd annual Ride to Fight On will start and end near ... Ride to Fight On is a cycling fundraiser that benefits the West Cancer Center, ... The University of Tennessee Health Science Center. A health and wellness festival featuring food, ...
Breaking Medicine News(10 mins):Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:March4thforWellBeing Foundation Kickoff 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3
... journal reportStudy highlights:, , ... of having cardiovascular disease within 10 years may not be sufficient ... adults 50 years and younger have a low 10-year risk because ... , Researchers suggest using a ...
... Much effort focuses on genetics and who would benefit ... New research may one day help physicians identify those ... benefit from certain treatments. , The discoveries, paving the ... the U.S. health-care system millions while sparing patients the ...
... ability of the Food and Drug Administration (FDA) to ... severely limited by lack of information, lack of resources ... critical areas, according to a new expert report released ... report, A Hard Pill To Swallow: Barriers to Effective ...
... partnership to deliver fire safety information to thousands ... the country prepares to inaugurate its first African ... worldwide will celebrate the legacy of ... partnering to distribute fire prevention and safety information ...
... Quality Forum (NQF) President and CEO Janet Corrigan will ... to provide guidance on how HIT investments can achieve ... quality of care our patients receive. NQF is a ... representing virtually every sector of the health care system. ...
... Lose Weight, Save Money and Be Healthy With Debut ... Pa., Jan. 14 In 2008, NutriSystem ... $3 a meal. To continue to help customers ... today a major innovation initiative themed "My NutriSystem. My ...
Cached Medicine News:Health News:Half of Adults 50 and Younger With Low 10-Year Risk of CVD Have High Lifetime Risk 2Health News:Half of Adults 50 and Younger With Low 10-Year Risk of CVD Have High Lifetime Risk 3Health News:Researchers Zero In on GI Cancers 2Health News:Researchers Zero In on GI Cancers 3Health News:Researchers Zero In on GI Cancers 4Health News:Nanotech in your vitamins 2Health News:American Red Cross and HOPE worldwide Honor Dr. Martin Luther King, Jr.'s Legacy 2Health News:American Red Cross and HOPE worldwide Honor Dr. Martin Luther King, Jr.'s Legacy 3Health News:NQF's Corrigan Tells Senate Committee That Investing in Health IT Holds Great Promise If It is Focused on Wringing Out Efficiencies and Coordinating Patient Care 2Health News:NutriSystem Introduces 'My NutriSystem. My Way!'(TM) 2Health News:NutriSystem Introduces 'My NutriSystem. My Way!'(TM) 3
(Date:7/31/2015)... 2015 Egalet Corporation (Nasdaq: EGLT ... focused on developing, manufacturing and marketing innovative pain ... announced underwritten public offering of 7,666,667 shares of ... of $11.25 per share. The shares of common ... upon the exercise in full by the underwriters ...
(Date:7/31/2015)... MONROVIA, Calif. , July 31, 2015  Xencor, ... developing engineered monoclonal antibodies for the treatment of autoimmune ... the appointment of Yujiro S. Hata to ... of experience in business and corporate development is a ... , Ph.D., president and chief executive officer of Xencor. ...
(Date:7/30/2015)... Edwards Lifesciences Corporation (NYSE: EW ), the global leader ... announced that Robert A. Ingram has retired from ... ardent champion for innovation in the lifesciences industry, and it ... board as we pursue our focused innovation strategy," said ... provided a valuable perspective to our board, drawing on his ...
Breaking Medicine Technology:Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 2Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 3Egalet Announces Closing of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares 4Xencor Appoints Yujiro S. Hata to Board of Directors 2Xencor Appoints Yujiro S. Hata to Board of Directors 3
... Results from Gene Identification Studies Presented at ASCO Support, ... ... REDWOOD CITY, Calif., May 31 Genomic Health,Inc. (Nasdaq: GHDX ... of two separate studies presented at the annual,meeting of the American ...
... from Phase III clinical trial --, CHICAGO, ... today announced the presentation of updated results from,a ... comparing,VELCADE and dexamethasone (VcD) to vincristine, adriamycin and,dexamethasone ... of,19 percent in the VcD arm as induction ...
Cached Medicine Technology:Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 2Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 3Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 4Genomic Health Announces Results of Initial Studies to Develop Predictive Tests for Targeted Therapies 5VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 2VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 3VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 4VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 5VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma 6
Gently curved jaws with fine angled sharp tips for puncture and grasping the capsule. Round handle is excellent for precise finger tip control. Made in titanium....
Regular tip. 1 mm x 13 mm. Serrated. Insulated....
Colibri style with 1.5 mm long angled tip and 0.12 mm teeth. Serrated handles with polished finish....
Straight shafts with 4 mm jaws. Serrated handle with dull finish. Jaws straight....
Medicine Products: